Zhi Peng, Changzheng Li, Xiang Wang, Yanqiao Zhang, Liuzhong Yang, Xiwen Huang, Ting Deng, Linzhi Lu, Hong Zong, Jun Zhang, Meili Sun, Dongyan Cai, Feng Ye, Wei Deng, Yin Jin, Jieer Ying, Jianzhi Liu, Dan Feng, Jianmin Fang, Lin Shen. "Disitamab vedotin (DV) plus toripalimab (Tor) and chemotherapy (Chemo)/trastuzumab (Tra) for first-line (1L) HER2-expressing locally advanced or metastatic (la/m) gastric cancer (GC): Updated results from the RC48-C027 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba4026